Clinical Trials In New York
Discover hundreds of clinical trials in New York.
Search clinical trials in New York by city, condition or phase.
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
Sponsor:
AbbVie
Location:
Code:
NCT04777357
Conditions
Depression
Bipolar I Disorder
Eligibility Criteria
Sex: All
Age: 10 - 17
Healthy Volunteers: Not accepted
Interventions
Cariprazine
Placebo
Academic-Community EPINET (AC-EPINET)
Sponsor:
Indiana University
Location:
Code:
NCT04497857
Conditions
Schizophrenia
Schizoaffective Disorder
Schizophreniform Disorders
Major Depression with Psychotic Features
Bipolar Disorder with Psychotic Features
Eligibility Criteria
Sex: All
Age: 16 - 35
Healthy Volunteers: Not accepted
Interventions
Coordinated Specialty Care (CSC)
Phase 1 Trial of ST-001 NanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
Sponsor:
SciTech Development, LLC
Location:
Code:
NCT04234048
Conditions
T-cell Lymphoma
Cutaneous/Peripheral T-Cell Lymphoma
Peripheral T-cell Lymphoma
Peripheral T-Cell Lymphoma, Not Classified
Primary Cutaneous T-cell Lymphoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Fenretinide
Accelerated TMS for Depression and OCD
Sponsor:
Weill Medical College of Cornell University
Location:
Code:
NCT04982757
Conditions
Depression
OCD
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
MagVenture MagPro System with Brainsight neuronavigation device
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome
Sponsor:
Janssen Research & Development, LLC
Location:
Code:
NCT05754957
Conditions
Acute Coronary Syndrome
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Milvexian
Placebo
A Biobehavioral Intervention for Young Men With Testicular Cancer
Sponsor:
UCLA
Location:
Code:
NCT04150848
Conditions
Testis Cancer
Eligibility Criteria
Sex: Male
Age: 18 - 39
Healthy Volunteers: Not accepted
Interventions
Goal-Focused Emotion Regulation Therapy (GET)
Individual Supportive Psychotherapy (ISP)
A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma
Sponsor:
National Cancer Institute (NCI)
Location:
Code:
NCT03871257
Conditions
Low Grade Glioma
Neurofibromatosis Type 1
Visual Pathway Glioma
Eligibility Criteria
Sex: All
Age: 2 - 21
Healthy Volunteers: Not accepted
Interventions
Carboplatin
Magnetic Resonance Imaging
Quality-of-Life Assessment
Questionnaire Administration
Selumetinib Sulfate
Study of RP1 Monotherapy and RP1 in Combination With Nivolumab
Sponsor:
Replimune Inc.
Location:
Code:
NCT03767348
Conditions
Cancer
Melanoma (Skin)
Mismatch Repair Deficiency
Microsatellite Instability
Non-melanoma Skin Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
RP1
nivolumab
A Phase I Trial of SIM1811-03 in Subjects With Advanced Solid Tumors and Cutaneous T-cell Lymphoma
Sponsor:
Jiangsu Simcere Pharmaceutical Co., Ltd.
Location:
Code:
NCT05569057
Conditions
Advanced Solid Tumor
Cutaneous T-cell Lymphoma (CTCL)
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
SIM1811-03
Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
Sponsor:
Novartis Pharmaceuticals
Location:
Code:
NCT04174157
Conditions
Spinal Muscular Atrophy (SMA)
Eligibility Criteria
Sex: All
Age: 0 - 70+
Healthy Volunteers: Not accepted
Interventions
Prospective observational registry
Zolgensma